Gallium Ga 68 dotatate: all 24 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and ParagangliomaRecruitingNCT07288931Not applicable
- Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakeRecruitingNCT07284589Phase 2
- Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast CancerRecruitingNCT06611891Phase 3
- Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid CarcinomaRecruitingNCT06520319Phase 1
- Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeRecruitingNCT02019706Phase 2
- Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT03448458Phase 2Results posted
- Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT ScanCompletedNCT03136328Phase 3Results posted
- Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisCompletedNCT02546388Not applicableResults posted
- GA-68 DOTA-TOC of Somatostatin Positive MalignanciesTerminatedNCT02177773Phase 1/2Results posted
- Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CTCompletedNCT01869725Phase 2Results posted
- Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 2Results posted
- Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETsActive, not recruitingNCT07119242Phase 3
- Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine TumorsCompletedNCT06091748Phase 3
- A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective StudyCompletedNCT05990998Phase 1/2
- Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIOStatus unknownNCT04689893Phase 1
- Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive SurgeryActive, not recruitingNCT04609592Phase 1
- Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOCWithdrawnNCT04298541Phase 2
- 68Ga-DOTATATE PET/CT in Neuroendocrine TumorStatus unknownNCT04041882Early Phase 1
- An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsActive, not recruitingNCT04040088Early Phase 1
- A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid TumorsWithdrawnNCT03057509Phase 1
- 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedNCT03001349Early Phase 1
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)CompletedNCT01879657Not applicable
- Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's PerspectiveCompletedNCT01873248Early Phase 1
- 68Ga-DOTATATE PET/CT in Oncogenic OsteomalaciaStatus unknownNCT01524016Early Phase 1